MustGrow Biologics Corp. (TSXV:MGRO)
0.6000
0.00 (0.00%)
Feb 20, 2026, 9:33 AM EST
MustGrow Biologics Revenue
MustGrow Biologics had revenue of 789.18K CAD in the quarter ending September 30, 2025, with 182.68% growth. This brings the company's revenue in the last twelve months to 7.54M, up 51.04% year-over-year. In the year 2024, MustGrow Biologics had annual revenue of 398.02K, down -91.55%.
Revenue (ttm)
7.54M
Revenue Growth
+51.04%
P/S Ratio
5.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 398.02K | -4.31M | -91.55% |
| Dec 31, 2023 | 4.71M | 4.71M | 72,630.36% |
| Dec 31, 2022 | 6.48K | -6.39K | -49.65% |
| Dec 31, 2021 | 12.87K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMustGrow Biologics News
- 3 days ago - MustGrow’s TerraMG targets Clubroot threat to Canada’s #1 crop - BNN Bloomberg
- 6 months ago - MustGrow Biologics Corp. GAAP EPS of -$0.02 beats by $0.02, revenue of $2.8M misses by $2.4M - Seeking Alpha
- 9 months ago - MustGrow Biologics GAAP EPS of -C$0.03 - Seeking Alpha
- 10 months ago - MustGrow Biologics accelerates regenerative agriculture with NexusBioAg acquisition - BNN Bloomberg
- 1 year ago - MustGrow Biologics proposes ~$2M private placement - Seeking Alpha